Ring in the New Year with Exclusive Discounts from The Business Research Company! Enjoy a 33% markdown on our Opportunities and Strategies Reports and a fantastic 25% off on our Global Market Reports. Don’t miss out on this limited-time offer to gain valuable insights and stay ahead in your industry
The Business Research Company’s Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Global Market Report 2024 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2024-2033. The Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Global Market Report 2023 evaluates exocrine pancreatic insufficiency (epi) therapeutics and diagnostics market size, growth rate, drivers, trends, and major companies.
The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12992&type=smp
The global exocrine pancreatic insufficiency (epi) therapeutics and diagnostics market is expected to grow from $5.24 billion in 2023 to $5.69 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increased prevalence of underlying conditions, advancements in diagnostic tools, pharmaceutical developments, rising global healthcare access. The exocrine pancreatic insufficiency (epi) therapeutics and diagnostics market size is expected to see strong growth in the next few years. It will grow to $7.67 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%.
The increasing number of people with diabetes is expected to propel the growth of the exocrine pancreatic insufficiency (EPI) therapeutics and diagnostics market going forward. Diabetes refers to a chronic metabolic disorder characterized by high blood sugar levels (hyperglycemia) over a prolonged period. This condition results from the body’s inability to produce enough insulin or effectively use the insulin it produces. EPI therapy, which involves pancreatic enzyme replacement therapy (PERT), can help improve nutrient absorption in people with diabetes and EPI. It can also help improve glycemic control in people with diabetes. For instance, in November 2021, according to the International Diabetes Federation, a Belgium-based umbrella organization of over 230 national diabetes associations, approximately 537 million adults (20–79 years old) were living with diabetes in 2021, whereas the total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. Therefore, the increasing number of people with diabetes is driving the growth of the exocrine pancreatic insufficiency (EPI) therapeutics and diagnostics market.
Get More Information On The Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Report:
The exocrine pancreatic insufficiency (epi) therapeutics and diagnostics market segments in the report are:
1) By Therapies: Nutritional Management, Pancreatic Enzyme Replacement Therapy (PERT), Lifestyle Modifications Approach
2) By Diagnostics: Blood Tests, Magnetic Resonance Imaging (MRI), Endoscopic Ultra-Sonography (EUS), Computerized Tomography (CT) Scanning
3) By Drug Type: Generic, Branded
4) By Distribution Channel: Direct Tender, Retail Pharmacy , Third-Party Distributor, Other Distribution Channels
5) By End User: Hospitals, Specialty Clinics, Homecare, Diagnostic Center, Research And Academic Institutes, Other End Users
The table of contents in TBRC’s exocrine pancreatic insufficiency (epi) therapeutics and diagnostics market report includes:
1. Executive Summary
2. Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Characteristics
3. Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Trends And Strategies
4. Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market – Macro Economic Scenario
5. Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Size and Growth
…
32. Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Competitive Benchmarking
33. Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market
35. Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Future Outlook and Potential Analysis
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Overview and Scope Plasma powder is a protein-rich ingredient derived from the spray-drying of plasma,…
Overview and Scope A pedestrian bridge is a constructed framework spanning a railway, river, or…
Overview and Scope Next-generation antibody therapeutics are advanced antibody-based drugs in structure, functionality, and therapeutic…
Overview and Scope A neurological biomarker is a substance that provides objective and quantifiable information…
Overview and Scope Home insurance is a policy that pays for expenses and damage to…
Overview and Scope Extended-release drugs are a dosage form made to release the medication over…